Airain Ltd’s Achillion Pharmaceuticals ACHN Stock Holding History

Airain Ltd’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$53K	Buy	+11,640	New	+$46.8K	﹤0.01%	803
2016 Q3	–	Sell	-22,554	Closed	-$176K	–	874
2016 Q2	$176K	Buy	+22,554	New	+$193K	0.01%	579
2015 Q3	–	Sell	-229,079	Closed	-$2.03M	–	1149
2015 Q2	$2.03M	Buy	+229,079	New	+$2.17M	0.11%	214
2015 Q1	–	Sell	-18,349	Closed	-$225K	–	1026
2014 Q4	$225K	Sell	18,349 -187,587	-91%	-$2.29M	0.02%	560
2014 Q3	$2.06M	Buy	205,936 +194,773	+1,745%	+$1.81M	0.14%	198
2014 Q2	$85K	Buy	+11,163	New	+$44.5K	0.01%	710

Other funds holding ACHN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Airain Ltd's ACHN Position: Q2 2017 in Review

Airain Ltd opened a new position in Achillion Pharmaceuticals (ACHN) in Q2 2017: 11,640 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #803 among its holdings. This is a return to the name: Airain Ltd previously reported a position in ACHN as recently as Q2 2016.

Airain Ltd first reported a position in ACHN in Q2 2014 and has held it in 6 quarters since. The position peaked at $2.06M in Q3 2014. 129 funds tracked by Wall St. Rank hold ACHN as of Q2 2017.

Airain Ltd held 11,640 shares of Achillion Pharmaceuticals worth $53K as of Q2 2017.
Achillion Pharmaceuticals was a new Airain Ltd position in Q2 2017.
Achillion Pharmaceuticals made up ﹤0.01% of Airain Ltd's portfolio in Q2 2017, its #803 holding.
Airain Ltd first reported a position in Achillion Pharmaceuticals in Q2 2014 and has held it in 6 quarters since.
Airain Ltd's Achillion Pharmaceuticals position peaked at $2.06M in Q3 2014.
129 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.